Almost three-quarters of skin cancers OK for Mohs surgery

Almost three-quarters of skin cancers OK for mohs surgery

(HealthDay)—Application of recently published appropriate-use criteria suggests Mohs micrographic surgery (MMS) can be used in nearly three-quarters of skin cancers, according to a study published in the July issue of the Journal of the American Academy of Dermatology.

Adam B. Blechman, M.D., from the University of Virginia Health System in Charlottesville, and colleagues retrospectively identified all biopsy-proven skin cancers, excluding invasive melanoma, treated over an eight-month period using (1,059 skin cancers). Use of MMS was classified as appropriate, inappropriate, or uncertain based on the appropriate-use criteria.

The researchers found that MMS was appropriate in 72.0 percent of cases, inappropriate in 20.4 percent, and uncertain in 7.6 percent. Just over half of skin cancers (59.3 percent) occurred in the following areas: head, neck, hands, feet, ankles, genitalia, nipples/areola, and pretibial surface.

"Using recently published appropriate-use criteria, 72.0 percent of skin cancers at this institution were appropriate for MMS," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Mohs surgery OK in seniors aged 90 years or older

Feb 08, 2013

(HealthDay)—Mohs micrographic surgery (MMS) is safe in seniors aged 90 years or older, according to a study published in the February issue of the Journal of the American Academy of Dermatology.

Few dermatology patients engage in skin CA surveillance

Jan 23, 2014

(HealthDay)—Few dermatology patients engage in skin cancer screening behaviors, and most have poor knowledge about melanoma, with lower understanding among minority patients, according to a study published ...

Skin cancer incidence up after pancreas transplantation

Sep 21, 2012

(HealthDay)—Nonmelanoma skin cancers (NMSCs) commonly occur after pancreas transplantation (PT), particularly in those who have a history of skin cancer, according to a study published in the October issue ...

Recommended for you

Aspirin may lower the risk for aggressive prostate cancer

5 minutes ago

Use of aspirin and/or other non-steroidal anti-inflammatory drugs (NSAIDs) was associated with a reduced risk for aggressive prostate cancer in men who had elevated prostate specific antigen (PSA) and a negative biopsy prior ...

User comments